Qingyan Lv

461 total citations
11 papers, 350 citations indexed

About

Qingyan Lv is a scholar working on Molecular Biology, Genetics and Microbiology. According to data from OpenAlex, Qingyan Lv has authored 11 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Microbiology. Recurrent topics in Qingyan Lv's work include CRISPR and Genetic Engineering (6 papers), Genetic Syndromes and Imprinting (3 papers) and Epigenetics and DNA Methylation (3 papers). Qingyan Lv is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Genetic Syndromes and Imprinting (3 papers) and Epigenetics and DNA Methylation (3 papers). Qingyan Lv collaborates with scholars based in China. Qingyan Lv's co-authors include Zhanjun Li, Lin Yuan, Liangxue Lai, Jichao Deng, Mao Chen, Yong Wang, Yuning Song, Tingting Sui, Jian Zeng and Yuan Liu and has published in prestigious journals such as Scientific Reports, FEBS Letters and Cellular and Molecular Life Sciences.

In The Last Decade

Qingyan Lv

11 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyan Lv China 6 300 138 23 20 17 11 350
Zicong Xie China 11 360 1.2× 262 1.9× 20 0.9× 15 0.8× 15 0.9× 25 475
Guanghua Su China 14 331 1.1× 156 1.1× 9 0.4× 37 1.9× 20 1.2× 59 477
Vivian M. Choi United States 9 582 1.9× 156 1.1× 15 0.7× 14 0.7× 69 4.1× 10 647
Xiaodong Zou China 10 209 0.7× 166 1.2× 15 0.7× 13 0.7× 7 0.4× 14 353
Derek Nedveck United States 7 351 1.2× 100 0.7× 13 0.6× 10 0.5× 40 2.4× 8 432
A. Mutto Argentina 9 243 0.8× 104 0.8× 6 0.3× 14 0.7× 9 0.5× 24 464
Yanwu Huo China 6 218 0.7× 61 0.4× 8 0.3× 5 0.3× 22 1.3× 8 295
Chi‐Hun Park South Korea 14 435 1.4× 335 2.4× 10 0.4× 21 1.1× 15 0.9× 26 550
Hongwei Xiao China 8 212 0.7× 129 0.9× 4 0.2× 55 2.8× 15 0.9× 20 304

Countries citing papers authored by Qingyan Lv

Since Specialization
Citations

This map shows the geographic impact of Qingyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyan Lv more than expected).

Fields of papers citing papers by Qingyan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyan Lv. The network helps show where Qingyan Lv may publish in the future.

Co-authorship network of co-authors of Qingyan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyan Lv. A scholar is included among the top collaborators of Qingyan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyan Lv. Qingyan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Shi, Jingru, et al.. (2025). Non‐Membrane Active Peptide Resensitizes MRSA to β‐Lactam Antibiotics and Inhibits S. aureus Virulence. Advanced Science. 12(15). e2416260–e2416260. 4 indexed citations
2.
Yang, Bingqing, Dan Fang, Qingyan Lv, Zhiqiang Wang, & Yuan Liu. (2021). Targeted Therapeutic Strategies in the Battle Against Pathogenic Bacteria. Frontiers in Pharmacology. 12. 673239–673239. 45 indexed citations
3.
Lv, Qingyan, Liangxue Lai, Lin Yuan, et al.. (2016). Tandem repeat knockout utilizing the CRISPR/Cas9 system in human cells. Gene. 582(2). 122–127. 5 indexed citations
4.
Lv, Qingyan, Lin Yuan, Jichao Deng, et al.. (2016). Efficient Generation of Myostatin Gene Mutated Rabbit by CRISPR/Cas9. Scientific Reports. 6(1). 25029–25029. 109 indexed citations
5.
Lv, Qingyan, Lin Yuan, Yuning Song, et al.. (2016). D-repeat in theXISTgene is required for X chromosome inactivation. RNA Biology. 13(2). 172–176. 22 indexed citations
6.
Yuan, Lin, Tingting Sui, Mao Chen, et al.. (2016). CRISPR/Cas9-mediated GJA8 knockout in rabbits recapitulates human congenital cataracts. Scientific Reports. 6(1). 22024–22024. 57 indexed citations
7.
Song, Yuning, Lin Yuan, Yong Wang, et al.. (2016). Efficient dual sgRNA-directed large gene deletion in rabbit with CRISPR/Cas9 system. Cellular and Molecular Life Sciences. 73(15). 2959–2968. 87 indexed citations
8.
Wang, Dongxu, Lin Yuan, Tingting Sui, et al.. (2015). Faithful expression of imprinted genes in donor cells of SCNT cloned pigs. FEBS Letters. 589(16). 2066–2072. 2 indexed citations
9.
Li, Xiaolan, Nan Song, Dongxu Wang, et al.. (2015). Isoform-specific imprinting of the MEST gene in porcine parthenogenetic fetuses. Gene. 558(2). 287–290. 9 indexed citations
10.
Yuan, Lin, Yuning Song, Anfeng Wang, et al.. (2015). Conservation of imprinting of Neuronatin (Nnat) in rabbits. SpringerPlus. 4(1). 257–257. 5 indexed citations
11.
Wang, Tiedong, et al.. (2014). DNA methylation-mediated silencing of neuronatin (NNAT) in pig parthenogenetic fetuses. Gene. 552(1). 204–208. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026